巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

Smith & Nephew plc

SNN
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・Smith & Nephew plc - 延遲價格・最後更新於 14/01 12:15
最高位
34.890
最低位
34.370
開市價
--
前收市價
34.860
成交量(千)
52.67
成交額(百萬)
15.19
買入
--
賣出
--
每手股數
--
市值(百萬)
15,338.91
市盈率
27.630
息率
2.15%
差價
--
52週高低
46.100 - 31.550
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
Smith & Nephew plc
證券代碼
SNN.US
所屬板塊
Medical Devices
公司業務
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
發行量
439475151
公司總部
Hatters Lane, Building 5, Croxley Park
公司網址
http://www.smith-nephew.com
公司電話
+44 1923477100
暫無內容

關於

Smith & Nephew plc(SNN.US)所屬的行業板塊為Medical Devices。
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
截至14/01 12:15:00,Smith & Nephew plc的股價升0.03,市值15,338.91百萬。Smith & Nephew plc的市盈率及息率分別為27.630及2.15%。
詳細公司背景可參考: http://www.smith-nephew.com